DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Naptumomab estafenatox
Naptumomab estafenatox
The Role of Epidermal Growth Factor Receptor in Cancer and Their Application Oncology Section for New Targeted Cancer Therapy
Modifications to the Harmonized Tariff Schedule of the United States to Implement Changes to the Pharmaceutical Appendix
Tanibirumab (CUI C3490677) Add to Cart
Free PDF Download
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
(INN) for Biological and Biotechnological Substances
Ep 3321281 A1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
Kidney Cancer
A Randomized Phase II/III Study of Naptumomab Estafenatox + Ifnα Versus Ifnα in Renal Cell Carcinoma
EP3027208T3.Pdf
INN Working Document 05.179 Update 2011
Factors Affecting the Pharmacology of Antibody–Drug Conjugates
Naptumomab Estafenatox for the Treatment of Renal Cell Carcinoma
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Immunotoxin Screening System: a Rapid and Direct Approach to Obtain Functional Antibodies with Internalization Capacities
The Chemistry Behind Adcs
Top View
View the Complete Poster Here
(INN) for Biological and Biotechnological Substances
WO 2014/075788 Al 22 May 2014 (22.05.2014) P O P C T
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
A61K9/51 (2006.01) — with International Search Report (Art
| Hao Hata Kata Tai Mit on a Man Taiwan Ta Material
Evolution of Escherichia Coli Expression System in Producing Antibody Recombinant Fragments
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
Monoclonal Antibodies in Non-Small-Cell Lung Cancer
Pharmaceutical Products and Chemical Intermediates, Fourth Review: Advice Concerning the Addition of Certain Products to the Pharmaceutical Appendix to the HTS
Com(2010)0397
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
International Journal of Current Advanced Research
Anti-Alphavbeta3 Monoclonal Antibody EMD 525797 (CUI C2830088) Add to Cart
(12) Patent Application Publication (10) Pub. No.: US 2011/0300186 A1 Hellstrom Et Al
Protein-Polymer-Drug Conjugates Protein-Polymer-Wirkstoffkonjugate Conjugués De Médicament-Protéine-Polymère
(INN) for Biological and Biotechnological Substances
The Chemistry Behind Adcs
Which Are the Antibodies to Watch in 2012?
Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin
Timepoint 1 Geting Assembly Complexes (Attacs) for Selectively Activating De¬ Sired Immune Cells in the Tumor Microenvironment
| Hai Laila a Et Antaloni Di Atas Tu
WO 2015/105926 Al 16 July 2015 (16.07.2015) P O PCT
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
(12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al